Anti-fungal Market Keeps to Growth Trend, Says Koncept Analytics in Its New Research Report Now Available at MarketPublishers.com
30 Nov 2016 • by Natalie Aster
LONDON – At present, the US ranks top market for anti-fungal drugs worldwide. The dominant companies specializing in anti-fungal dugs are active in the country’s market.
The world’s anti-fungal market is keeping to a growth trend, spurred by a number of favourable factors, including increasing incidence of fungal infections, rising number of people suffering from cancer, increasing spending on medicines, escalating sales of prescription drugs, amid others.
However, growth in this market could be hampered by drug resistance, harsh side effects, lack of novel anti-fungal therapeutic options and high cost of anti-fungal drugs.
Top trends in the worldwide market for anti-fungal drugs include increase in development of novel drugs, enhancing awareness and also flourishing public-private partnerships in pharmaceutical industry.
The cutting-edge research report “Global Antifungal Market: Industry Analysis & Outlook (2016-2020)” created by Koncept Analytics comprises an all-round analysis of the world’s anti-fungal market, reviews the scenario across the key geographical markets, uncovers trustworthy statistics, contains a granular analysis of the market and also examines the major factors limiting and driving the anti-fungal market growth. The research publication investigates the competitive environment and gives info on top participants. Additionally, a five-year future outlook for the world’s anti-fungal market is at hand in the report.
For other insightful research reports by this publisher are offered in the Koncept Analytics catalogue at MarketPublishers.com.